Clinical Trial

Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

Name: Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study — clinical trial record (NCT06642831)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PHOEBE

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women.

Trial Details

NCT Number	NCT06642831
Lead Sponsor	University Hospital Erlangen Collaborators: Roche Diagnostics International AG
Conditions	Polycystic Ovarian Syndrome (PCOS)
Enrollment	380 participants
Start Date	2023-01-31
Primary Completion	2026-12 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2024-10-15